Amyris (Nasdaq: AMRS ) is expected to report Q1 earnings around April 30. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Amyris's revenues will decrease -66.7% and EPS will remain in the red.
The average estimate for revenue is $9.8 million. On the bottom line, the average EPS estimate is -$0.39.
Last quarter, Amyris logged revenue of $5.9 million. GAAP reported sales were 86% lower than the prior-year quarter's $41.5 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at -$0.49. GAAP EPS were -$0.72 for Q4 versus -$1.30 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 7.4%, much better than the prior-year quarter. Operating margin was -598.5%, much worse than the prior-year quarter. Net margin was -742.9%, much worse than the prior-year quarter.
The full year's average estimate for revenue is $93.8 million. The average EPS estimate is -$1.22.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 74 members out of 86 rating the stock outperform, and 12 members rating it underperform. Among 12 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), seven give Amyris a green thumbs-up, and five give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Amyris is hold, with an average price target of $3.50.
Is Amyris the right energy stock for you? Read about a handful of timely, profit-producing plays on expensive crude in "3 Stocks for $100 Oil." Click here for instant access to this free report.
- Add Amyris to My Watchlist.